Abstract PD13-03: Genomic profiling of breast cancer leptomeningeal metastasis (BCLM) reveals a divergent evolution and therapeutic targets (2021)

First Author: Fitzpatrick A

Attributed to: Identifying molecular drivers and early diagnostic biomarkers in breast cancer leptomeningeal metastasis by the interrogation of cerebrospinal fluid funded by MRC

No abstract provided

Type: Journal Article/Review

Parent Publication: Cancer Research

Issue: 4_Supplement